while our lawyer argued that their amount was not only a trivial fraction of what we stood to lose if it affected a launched product, it was less than we'd lose if we had to walk away from an early stage program.
I was once on the other side of that argument: a service provider specializing in work for pharmaceutical companies wanted a low liability cap--for issues including IP leak, which can torpedo a product--
